Tonira Pharma (Delisted) financials and balance sheet

BSE: 530155

Last traded ₹19.75 on 29 May 2012

Delisted on 22 Jun 2012.

4 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Tonira Pharma annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹41 Cr, year to Mar 2009A loss in the year to Mar 2011, −₹2.08 Cr

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2011

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue30
  2. Other income+0.1
  3. One-off items+0.6
  4. Finance costs−3.0
  5. Profit before tax−2.2
  6. Tax+0.1
  7. Net profit−2.1

Profit and loss

Standalone, ₹ crore, years to March.Tonira Pharma quarterly results

₹ croreMar 2008Mar 2009Mar 2010Mar 2011
Revenue from operations32.441.236.830.0
33.6–––
Materials and goods bought17.2–––
Operating profit before depreciation−1.2–––
Operating margin−3.7%–––
Depreciation and amortisation2.8–––
Operating profit after depreciation−4.0–––
Other income0.60.40.00.1
Finance costs1.93.52.73.0
Profit before one-off items and tax–3.90.8−2.8
One-off items–−1.60.50.6
Profit before tax−5.32.31.3−2.2
Tax−3.40.40.3−0.1
Net profit−5.8−0.71.0−2.1
Net margin−18.0%−1.8%2.8%−6.9%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2009, Mar 2010 and Mar 2011: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2008Mar 2009Mar 2010Mar 2011
Market cap at the year end (₹ crore)21.611.2–14.8

Ratios

Standalone, years to March.

RatioMar 2009Mar 2010Mar 2011
Revenue growth27.2%−10.7%−18.4%
Interest cover is left blank for the year to Mar 2008: operating profit after depreciation is a loss, and a loss covers no interest bill.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2011.

Measure5 years3 years
Revenue growth, yearly rate–−2.5%
Net margin, average−6.0%−2.0%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2009Mar 2010Mar 2011
Effective tax ratePublished threshold 17.16 per cent16.7923.81–
A threshold marked as ours has no published figure; it is the line we read the check against.